Sponsor Pipeline

Mohammed Milhem Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05363631 Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab Clear Cell Renal Cell Carcinoma Active, Not Recruiting
Phase 1
NCT07404332 5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors Solid Tumor Recruiting
NCT03173976 Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial Chondrosarcoma Active, Not Recruiting
Disease Areas
Sarcoma (1) Kidney Cancer (1)
Get alerts when Mohammed Milhem's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free